Neural Pathways, a subsidiary company of Active Assistance which is the Montreux Healthcare Fund’s operating company, recently received the Health Investor award for “Community Support Provider of the Year”. The Health Investor Awards promote excellence and recognise innovation within the independent healthcare sector.

The judges cited Neural Pathways for: “bringing together a diverse team of experts to pioneer and innovate new treatments and technologies”. They placed specific focus on the ‘Virtual Rehabilitation Beds’ concept which allows effective care of service users with complex needs from home. There is an increasing body of research which references environmental influences on rehabilitation as being crucial and hence, the ability to deliver home care to service users with such high acuity is life changing.

Oliver Harris, CEO, Montreux Capital Management (UK) stated: “We are very pleased to see Neural Pathways has received this award. Care Quality is the very core of what we do and hence, it is very encouraging for everyone involved that this hard work has been awarded. We recognise and champion the difference that innovative approaches and technological change can have on this sector, we will continue to push boundaries to improve front line care in our business.

Active Assistance’s award cabinet is growing ever larger and we hope that our day to day successes continue to be recognised on a national level.”

Find Us

Thameside House
Hurst Road
East Molesey
KT8 9AY

T: + 44 (0) 1932 860 140
E: info@montreuxcm.com

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together “the Sponsors,” or “Sponsor”) do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.

ACCEPT